• Mashup Score: 0

    Mashup Media, LLC, publisher of GU Oncology Now, in partnership with The Uromigos—Thomas Powles, MD, and Brian Rini, MD, FASCO—are set to host the second annual The Uromigos Live & Unplugged event in Nashville, Tennessee, on November 3-4 at the Virgin Hotels Nashville. The 2-day meeting will include individual panel sessions on blad der, prostate, and renal cell cancer. The latest hot topics in the genitourinary oncology world will be covered in a casual and conversational format that will be both

    Tweet Tweets with this article
    • What makes #UromigosLive different from other conferences and events? Dr. Michael Morris fills us in on the discussion and debate you won't find anywhere else. Be sure to see how you can tune in to @Uromigos: Live & Unplugged in November: https://t.co/3Ue6mE9rQh https://t.co/S0fdWO7Kr8

  • Mashup Score: 5

    Abstract Background The Society for Cardiovascular Angiography and Interventions (SCAI) shock classification has been shown to provide robust mortality risk stratification in a variety of cardiovas…

    Tweet Tweets with this article
    • The @SCAI shock classification effectively risk-stratifies cardiac surgery #ICU patients for hospital mortality, postoperative complications & organ dysfunction, thus proving its clinical usefulness in the field of #cvSurg. https://t.co/FwoRt31vYC #CardioTwitter #CriticalCare https://t.co/78AEWmrvjj

  • Mashup Score: 0

    We’re daring to improve the quality of life for every child with blood cancer, daring to dream of them thriving. Find out more about the Leukemia and Lymphoma Society!

    Tweet Tweets with this article
    • With the Dare to Dream Project, we’re powering innovative research, new, safer treatments, support services, and advocacy for kids. Learn more about the Dare to Dream Project 👉 https://t.co/jpEF0BYlWh

  • Mashup Score: 4

    The American Society of Clinical Oncology and Association for Clinical Oncology (ASCO) are urging members of the Senate Committee on Health, Education, Labor, and Pensions to approve the nomination

    Tweet Tweets with this article
    • ASCO urges members of Senate HELP Committee to promptly confirm the nomination of @NCIDirector Dr. Monica M. Bertagnolli as the 17th Director of the @NIH: https://t.co/64TpM10yHv https://t.co/1FxWZTirwC

  • Mashup Score: 0

    Merck has announced that the phase 3 AMBASSADOR trial (KEYNOTE-123) evaluating KEYTRUDA (pembrolizumab) has met one of its dual primary endpoints of disease-free survival (DFS) for the adjuvant treatment of patients with localized muscle-invasive bladder cancer (MIBC) and locally advanced urothelial carcinoma. “Up to half of patients with bladder cancer who undergo surgery will experience recurrence within a year, underscoring the need for new treatment options in the adjuvant setting,” said Marjorie

    Tweet Tweets with this article
    • In a recent press release, @Merck has announced that the phase 3 AMBASSADOR trial evaluating #pembrolizumab for the adjuvant treatment of #MIBC has met one of its dual primary endpoints of DFS. Read more: https://t.co/jR7AOUU9u2 https://t.co/ex557m7dTO